Catalent Inc.

63.48
0.00 (0.00%)
At close: Dec 17, 2024, 9:00 PM

Catalent Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018
Biologics Revenue 461.00M 605.00M 461.00M 438.00M 448.00M 475.00M 580.00M 523.00M 667.00M 698.00M 638.00M 546.00M 603.30M 543.70M 403.90M 377.10M 357.80M 250.00M 225.20M 188.60M 231.10M 172.10M 184.30M 154.60M
Biologics Revenue Growth -23.80% +31.24% +5.25% -2.23% -5.68% -18.10% +10.90% -21.59% -4.44% +9.40% +16.85% -9.50% +10.96% +34.61% +7.11% +5.39% +43.12% +11.01% +19.41% -18.39% +34.28% -6.62% +19.21% n/a
PharmaConsumerHealth Revenue 563.00M 697.00M 613.00M 587.00M 534.00M 563.00M 570.00M 499.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PharmaConsumerHealth Revenue Growth -19.23% +13.70% +4.43% +9.93% -5.15% -1.23% +14.23% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Jun 30, 2024Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018Jun 30, 2017Jun 30, 2016Jun 30, 2015Jun 30, 2014
Europe Revenue 1.36B 1.51B 1.34B 976.10M 842.10M 897.80M 797.40M 733.20M 795.40M 888.80M
Europe Revenue Growth -9.76% +12.14% +37.59% +15.91% -6.20% +12.59% +8.76% -7.82% -10.51% n/a
United States Revenue 2.82B 3.11B 2.46B n/a n/a 1.22B 996.40M 858.60M 799.30M 682.30M
United States Revenue Growth -9.23% +26.32% n/a n/a n/a +22.42% +16.05% +7.42% +17.15% n/a

Create Price Alert on CTLT

Your price alert will notify you when the stock price is above 63.48.

Add to Watchlist